VictORION-INCLUSION: Evaluating Inclisiran for Cholesterol Managment in Heart Disease
Public ClinicalTrials.gov record NCT06249165. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
VictORION-INCLUSION: Evaluating INClisiran as a soLUtion to Improve LDL-C Management and cloSe Care Gaps in an Inclusive ASCVD and ASCVD Risk Equivalent populatiON
Study identification
- NCT ID
- NCT06249165
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Duke University
- Other
- Enrollment
- 130 participants
Conditions and interventions
Conditions
Interventions
- Inclisiran Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 15, 2024
- Primary completion
- Nov 30, 2026
- Completion
- Jan 31, 2027
- Last update posted
- Nov 5, 2025
2024 – 2027
United States locations
- U.S. sites
- 23
- U.S. states
- 16
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Univ. of Alabama - Birmingham | Birmingham | Alabama | 35205 | — |
| Univ. of California - Irvine | Orange | California | 92868 | — |
| San Francisco General Hospital | San Francisco | California | 94110 | — |
| Emory University | Atlanta | Georgia | 30324 | — |
| Wellstar Paulding | Hiram | Georgia | 30141 | — |
| Rush University | Chicago | Illinois | 60612 | — |
| University of Iowa | Iowa City | Iowa | 52242 | — |
| JHU - Suburban Hospital | Bethesda | Maryland | 20814 | — |
| Johns Hopkins | Columbia | Maryland | 21044 | — |
| Essentia Health | Duluth | Minnesota | 55805 | — |
| University of Missouri | Columbia | Missouri | 65212 | — |
| Washington University | St Louis | Missouri | 63110 | — |
| University of Nebraska | Omaha | Nebraska | 68198 | — |
| Heart House of NJ | Haddon Heights | New Jersey | 08035 | — |
| University of North Carolina | Chapel Hill | North Carolina | 27514 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Wake Forest University | Winston-Salem | North Carolina | 27157 | — |
| Temple University | Philadelphia | Pennsylvania | 19140 | — |
| Medical Univ. of South Carolina | Charleston | South Carolina | 29403 | — |
| Houston Methodist | Houston | Texas | 77030 | — |
| Baylor Scott & White - Waco | Waco | Texas | 76708 | — |
| University of Utah | Salt Lake City | Utah | 84132 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06249165, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 5, 2025 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06249165 live on ClinicalTrials.gov.